Table 1 Baseline characteristics of the study participants
Variables | Total | RHR (bpm) | p | ||
|---|---|---|---|---|---|
n = 2188 | < 80 | 80–99 | ≥ 100 | ||
n = 260 | n = 1162 | n = 766 | |||
Sex, n (%) | |||||
Male | 1894 (86.6) | 211 (81.2) | 998 (85.9) | 685 (89.4) | 0.002 |
Female | 294 (13.4) | 49 (18.8) | 164 (14.1) | 81 (10.6) | |
Age, Mean ± SD | 45.3 ± 15.2 | 52.3 ± 14.9 | 46.5 ± 15.2 | 41.2 ± 14.0 | < 0.001 |
CD4, Mean ± SD | 92.8 ± 131.4 | 151.0 ± 178.1 | 97.4 ± 129.6 | 66.1 ± 106.1 | < 0.001 |
CD8, Mean ± SD | 560.4 ± 616.8 | 620.2 ± 668.8 | 600.3 ± 697.2 | 479.5 ± 433.8 | < 0.001 |
First confirmed, n (%) | |||||
No | 659 (30.1) | 84 (32.3) | 334 (28.7) | 241 (31.5) | 0.422 |
Yes | 1512 (69.1) | 173 (66.5) | 818 (70.4) | 521 (68) | |
N/A | 17 (0.8) | 3 (1.2) | 10 (0.9) | 4 (0.5) | |
First ART, n (%) | |||||
No | 749 (34.2) | 106 (40.8) | 395 (34) | 248 (32.4) | 0.077 |
Yes | 1420 (64.9) | 151 (58.1) | 755 (65) | 514 (67.1) | |
N/A | 19 (0.9) | 3 (1.2) | 12 (1) | 4 (0.5) | |
60-day mortality, n (%) | |||||
No | 2078 (95.0) | 245 (94.2) | 1121 (96.5) | 712 (93) | 0.002 |
Yes | 110 (5.0) | 15 (5.8) | 41 (3.5) | 54 (7) | |
Temperature, Mean ± SD | 37.0 ± 0.8 | 36.7 ± 0.5 | 37.0 ± 0.8 | 37.2 ± 0.9 | < 0.001 |
Impaired liver function, n (%) | |||||
No | 1590 (72.7) | 196 (75.4) | 795 (68.4) | 599 (78.2) | < 0.001 |
Yes | 598 (27.3) | 64 (24.6) | 367 (31.6) | 167 (21.8) | |
Lung infections, n (%) | |||||
No | 930 (42.5) | 133 (51.2) | 477 (41) | 320 (41.8) | 0.01 |
Yes | 1258 (57.5) | 127 (48.8) | 685 (59) | 446 (58.2) | |
Cancer, n (%) | |||||
No | 2098 (95.9) | 249 (95.8) | 1108 (95.4) | 741 (96.7) | 0.325 |
Yes | 90 (4.1) | 11 (4.2) | 54 (4.6) | 25 (3.3) | |
Tuberculosis, n (%) | |||||
No | 1818 (83.1) | 230 (88.5) | 931 (80.1) | 657 (85.8) | < 0.001 |
Yes | 370 (16.9) | 30 (11.5) | 231 (19.9) | 109 (14.2) | |
Cardiovascular disease, n (%) | |||||
No | 1988 (90.9) | 227 (87.3) | 1050 (90.4) | 711 (92.8) | 0.02 |
Yes | 200 (9.1) | 33 (12.7) | 112 (9.6) | 55 (7.2) | |
Impaired renal function, n (%) | |||||
No | 2101 (96.0) | 252 (96.9) | 1114 (95.9) | 735 (96) | 0.729 |
Yes | 87 (4.0) | 8 (3.1) | 48 (4.1) | 31 (4) | |
Gastrointestinal bleeding, n (%) | |||||
No | 2169 (99.1) | 259 (99.6) | 1156 (99.5) | 754 (98.4) | 0.05 |
Yes | 19 (0.9) | 1 (0.4) | 6 (0.5) | 12 (1.6) | |
Diabetes, n (%) | |||||
No | 2051 (93.7) | 245 (94.2) | 1076 (92.6) | 730 (95.3) | 0.053 |
Yes | 137 (6.3) | 15 (5.8) | 86 (7.4) | 36 (4.7) | |
Hypertension, n (%) | |||||
No | 1982 (90.6) | 227 (87.3) | 1043 (89.8) | 712 (93) | 0.01 |
Yes | 206 (9.4) | 33 (12.7) | 119 (10.2) | 54 (7) | |
Auricular fibrillation, n (%) | |||||
No | 2166 (99.0) | 256 (98.5) | 1150 (99) | 760 (99.2) | 0.514 |
Yes | 22 (1.0) | 4 (1.5) | 12 (1) | 6 (0.8) | |
Electrolyte disturbance, n (%) | |||||
No | 1299 (59.4) | 173 (66.5) | 633 (54.5) | 493 (64.4) | < 0.001 |
Yes | 889 (40.6) | 87 (33.5) | 529 (45.5) | 273 (35.6) | |